Additional Information
Short Description: |
GSK-3 kinase inhibitor |
Research Area: |
Cell Signaling, Cancer, Apoptosis, Cancer Growth Inhibitors, Tyrosine Kinase Inhibitors |
Alternative Name(s): |
N-(4-Methoxybenzyl)-N′-(5-nitro-1,3-thiazol-2-yl)urea |
Category: |
Small Molecules |
Product Type: |
Inhibitor |
CAS No.: |
487021-52-3 |
Molecular Formula: |
C12H12N4O4S |
Molecular Weight: |
308,3 |
Source: |
Synthetic |
Purity: |
≥95% (HPLC) |
Solubility: |
Soluble in DMSO, methanol, 100% ethanol or ethyl acetate |
Appearance: |
White to off-white solid |
Storage: |
-20ºC |
Shipping: |
Shipped Ambient |
SMILES: |
COC1=CC=C(C=C1)CNC(=O)NC2=NC=C(S2)[N+](=O)[O-] |
InChI: |
InChI=1S/C12H12N4O4S/c1-20-9-4-2-8(3-5-9)6-13-11(17)15-12-14-7-10(21-12)16(18)19/h2-5,7H,6H2,1H3,(H2,13,14,15,17) |
InChIKey: |
YAEMHJKFIIIULI-UHFFFAOYSA-N |
Field of Use: |
For in vitro research use only. |
Related Products
GSK-3 Inhibitor, AR-A014418 | 1953
26
NULL297.00
Cell-permeable. A selective glycogen synthase kinase 3 (GSK-3) inhibitor (IC₅₀ = 104 nM). Inhibition is competitive with respect to ATP (Ki = 38nM). Exhibits specificity for GSK-3 over cdk2 and cdk5...
26-1953-GEN
